SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    John J. Chen, Fiona Costello, Randy H. Kardon, Sex Disparities in Neuro-Ophthalmologic Disorders, Current Eye Research, 2015, 40, 2, 247

    CrossRef

  2. 2
    James W. Denham, Michael Nowitz, David Joseph, Gillian Duchesne, Nigel A. Spry, David S. Lamb, John Matthews, Sandra Turner, Chris Atkinson, Keen-Hun Tai, Nirdosh Kumar Gogna, Lizbeth Kenny, Terry Diamond, Richard Smart, David Rowan, Pablo Moscato, Renato Vimieiro, Richard Woodfield, Kevin Lynch, Brett Delahunt, Judy Murray, Cate D'Este, Patrick McElduff, Allison Steigler, Allison Kautto, Jean Ball, Impact of androgen suppression and zoledronic acid on bone mineral density and fractures in the Trans-Tasman Radiation Oncology Group (TROG) 03.04 Randomised Androgen Deprivation and Radiotherapy (RADAR) randomized controlled trial for locally advanced prostate cancer, BJU International, 2014, 114, 3
  3. 3
    Ali-Asghar Zhumkhawala, Joseph M. Gleason, T. Craig Cheetham, Fang Niu, Ronald K. Loo, Richard M. Dell, Steven J. Jacobsen, Gary W. Chien, Osteoporosis Management Program Decreases Incidence of Hip Fracture in Patients With Prostate Cancer Receiving Androgen Deprivation Therapy, Urology, 2013, 81, 5, 1010

    CrossRef

  4. You have free access to this content4
    Rebecca Siegel, Carol DeSantis, Katherine Virgo, Kevin Stein, Angela Mariotto, Tenbroeck Smith, Dexter Cooper, Ted Gansler, Catherine Lerro, Stacey Fedewa, Chunchieh Lin, Corinne Leach, Rachel Spillers Cannady, Hyunsoon Cho, Steve Scoppa, Mark Hachey, Rebecca Kirch, Ahmedin Jemal, Elizabeth Ward, Cancer treatment and survivorship statistics, 2012, CA: A Cancer Journal for Clinicians, 2012, 62, 4
  5. 5
    Heather Millar, Joyce Davison, Nutrition Education for Osteoporosis Prevention in Men With Prostate Cancer Initiating Androgen Deprivation Therapy, Clinical Journal of Oncology Nursing, 2012, 16, 5, 497

    CrossRef

  6. 6
    Melinda J. Craike, Patricia M. Livingston, Mari Botti, An exploratory study of the factors that influence physical activity for prostate cancer survivors, Supportive Care in Cancer, 2011, 19, 7, 1019

    CrossRef

  7. 7
    Amit R. Patel, Andrew J. Stephenson, Radiation therapy for prostate cancer after prostatectomy: adjuvant or salvage?, Nature Reviews Urology, 2011, 8, 7, 385

    CrossRef

  8. 8
    Jean-Baptiste Lattouf, Fred Saad, Bone complications of androgen deprivation therapy: screening, prevention, and treatment, Current Opinion in Urology, 2010, 20, 3, 247

    CrossRef

  9. 9
    John Araujo, Christopher Logothetis, Targeting Src signaling in metastatic bone disease, International Journal of Cancer, 2009, 124, 1
  10. 10
    Hakki Perk, Mustafa Yildiz, Alim Kosar, Sureyya Cerci, Feray Soyupek, Alper Ozorak, Cem Dilmen, Correlation between BMD and bone scintigraphy in patients with prostate cancer, Urologic Oncology: Seminars and Original Investigations, 2008, 26, 3, 250

    CrossRef

  11. 11
    D A Galvão, K Nosaka, D R Taaffe, J Peake, N Spry, K Suzuki, K Yamaya, M R McGuigan, L J Kristjanson, R U Newton, Endocrine and immune responses to resistance training in prostate cancer patients, Prostate Cancer and Prostatic Diseases, 2008, 11, 2, 160

    CrossRef

  12. 12
    Jacqueline S. Drouin, Jerome Beeler, Exercise and urologic cancers, Urologic Oncology: Seminars and Original Investigations, 2008, 26, 2, 205

    CrossRef

  13. 13
    Ron S. Israeli, Christopher W. Ryan, Laura L. Jung, Managing Bone Loss in Men With Locally Advanced Prostate Cancer Receiving Androgen Deprivation Therapy, The Journal of Urology, 2008, 179, 2, 414

    CrossRef

  14. 14
    P. Hadji, J. -J. Body, M. S. Aapro, A. Brufsky, R. E. Coleman, T. Guise, A. Lipton, M. Tubiana-Hulin, Practical guidance for the management of aromatase inhibitor-associated bone loss, Annals of Oncology, 2008, 19, 8, 1407

    CrossRef

  15. 15
    Sung Joon Hong, Kang Su Cho, Han Yong Choi, Hanjong Ahn, Choung-Soo Kim, Byung Ha Chung, A Prospective, Multicenter, Open-label Trial of Zoledronic Acid in Patients with Hormone Refractory Prostate Cancer, Yonsei Medical Journal, 2007, 48, 6, 1001

    CrossRef

  16. You have free access to this content16
    Paulo Rodrigues, Flavio O Hering, Paulo Bruna, Alex Meller, Yuri Afonso, Comparative study of the protective effect of different intravenous bisphosphonates on the decrease in bone mineral density in patients submitted to radical prostatectomy undergoing androgen deprivation therapy. A prospective open-label controlled study, International Journal of Urology, 2007, 14, 4
  17. 17
    Eun-Sun Hwang, Phyllis E. Bowen, DNA Damage, a Biomarker of Carcinogenesis: Its Measurement and Modulation by Diet and Environment, Critical Reviews in Food Science and Nutrition, 2007, 47, 1, 27

    CrossRef

  18. 18
    Ellen F. T. Yee, Robert E. White, Glen H. Murata, Christine Handanos, Richard M. Hoffman, Osteoporosis Management in Prostate Cancer Patients Treated with Androgen Deprivation Therapy, Journal of General Internal Medicine, 2007, 22, 9, 1305

    CrossRef

  19. 19
    Marilyn L. Haas, Katen Moore, Osteoporosis: An Invisible, Undertreated, and Neglected Disease of Elderly Men, Journal of Elder Abuse & Neglect, 2007, 19, 1-2, 61

    CrossRef

  20. 20
    Fred Saad, Bone-Directed Treatments for Prostate Cancer, Hematology/Oncology Clinics of North America, 2006, 20, 4, 947

    CrossRef

  21. 21
    Jacques-Pierre Moreau, Patrick Delavault, Joëlle Blumberg, Luteinizing hormone-releasing hormone agonists in the treatment of prostate cancer: A review of their discovery, development, and place in therapy, Clinical Therapeutics, 2006, 28, 10, 1485

    CrossRef

  22. 22
    Fred Saad, Noel Clarke, Marc Colombel, Natural History and Treatment of Bone Complications in Prostate Cancer, European Urology, 2006, 49, 3, 429

    CrossRef

  23. 23
    Rabih Hijazi, Glenn R. Cunningham, Handbook of Models for Human Aging, 2006,

    CrossRef

  24. 24
    Rabih A. Hijazi, Glenn R. Cunningham, Andropause: Is Androgen Replacement Therapy Indicated for the Aging Male?*, Annual Review of Medicine, 2005, 56, 1, 117

    CrossRef

  25. 25
    Daniel M. Janoff, Chad Peterson, Solange Mongoue-Tchokote, Laura Peters, Tomasz M. Beer, Emily M. Wersinger, Motomi Mori, Mark Garzotto, Clinical outcomes of androgen deprivation as the sole therapy for localized and locally advanced prostate cancer, BJU International, 2005, 96, 4
  26. 26
    Allen C. Chen, Daniel P. Petrylak, Complications of androgen-deprivation therapy in men with prostate cancer, Current Urology Reports, 2005, 6, 3, 210

    CrossRef

  27. 27
    Theresa A. Guise, James A. Eastham, Cancer Treatment-Induced Bone Loss (CTIBL) in Prostate Cancer: Pathophysiology, Preclinical Findings, and Treatment with Zoledronic Acid, European Urology Supplements, 2004, 3, 5, 46

    CrossRef

  28. 28
    Allen C. Chen, Daniel P. Petrylak, Complications of androgen deprivation therapy in men with prostate cancer, Current Oncology Reports, 2004, 6, 3, 209

    CrossRef

  29. 29
    P DICKMAN, J ADOLFSSON, K ASTROM, G STEINECK, HIP FRACTURES IN MEN WITH PROSTATE CANCER TREATED WITH ORCHIECTOMY, The Journal of Urology, 2004, 172, 6, 2208

    CrossRef

  30. 30
    Henry G. Bone, Werner Schurr, Intravenous bisphosphonate therapy for osteoporosis: Where do we stand?, Current Osteoporosis Reports, 2004, 2, 1, 24

    CrossRef

  31. 31
    Harlan Stock, Adina Schneider, Elton Strauss, Osteoporosis, Clinical Orthopaedics and Related Research, 2004, 425, 143

    CrossRef

  32. 32
    Fred Saad, Preventing Bone Complications in Patients with Prostate Cancer: The Emerging Role of Zoledronic Acid, European Urology Supplements, 2004, 3, 5, 25

    CrossRef

  33. 33
    E. David Crawford, Skeletal Complications in Men with Prostate Cancer: Effects on Quality-of-Life Outcomes throughout the Continuum of Care, European Urology Supplements, 2004, 3, 5, 10

    CrossRef

  34. 34
    Fred Saad, Carl Olsson, Claude C. Schulman, Skeletal Morbidity in Men with Prostate Cancer: Quality-of-Life Considerations throughout the Continuum of Care, European Urology, 2004, 46, 6, 731

    CrossRef

  35. 35
    Darren Hargrave, Boo Messahel, Piers Plowman, Paediatric Oncology, Third edition, 2004,

    CrossRef